Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines
R. Wang, L. V. N. Oliveira, M. M. Hester, D. M. Carlson, D. Christensen, C. A. Specht, S. M. Levitz
This paper develops multivalent cryptococcal vaccines using CAF01 adjuvant that protect mice from experimental cryptococcosis by inducing IFNγ and IL-17 responses.
bioRxiv · Apr 24, 2024 · PreprintImmunology